5-chloro-3-(2-methoxyethyl)-1,2,4-thiadiazole, 95.0%, 1g

3-Hydroxy-N-phenyl-2-naphthamide, 95.0%, 25g

8-Fluoro-1,2,3,4-tetrahydroquinoline, 97%, 100mg

7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-amine, 95.0%, 5g

2-Chloro-4,5-dimethylpyridine, 96%, 250mg

N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine>97.0%(T)5g

2-AMINO-4-BROMO-5-FLUOROBENZOIC ACID, 95.0%, 5g

4-BROMO-8-NITROISOQUINOLINE, 95.0%, 1g

N-Methylmorpholine, min 98.5%, for synthesis, 250mL, glass packaging

2,2',4'-Trimethylpropiophenone, 97.0%, 1g

1-Benzyl-3-(pyridin-3-yl)piperazine>95.0%(GC)100mg

1,3,4,6-Tetrakis(methoxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione, 95.0%, 500g

Methyl 3-phenyl-1H-pyrazole-5-carboxylate, 95.0%, 10g